title: [A new therapeutic option for diabetes patients].
abstract: Type I diabetes often raises therapy problems because the patients compliance is related to the insulin injections needed all life long. In these circumstances, the authors review a new therapeutic option--inhaled insulin. In order to be convincing about this future treatment, the article reviews: the history of the discovery, pharmacokinetic aspects, results of clinical studies and patients adherence to this new kind of substitution treatment of human insulin deficiency.
authors.affiliation: Institutul de Pneumologie "Marius Nasta", Bucureşti. mihaltan@starnets.ro
authors.forename: Fl
authors.initials: F
authors.lastname: Mihălţan
authors.forename: Ruxandra
authors.initials: R
authors.lastname: Ulmeanu
authors.forename: Ruxandra
authors.initials: R
authors.lastname: Râşnoveanu
mesh_terms: D000280:Administration, Inhalation; D002986:Clinical Trials as Topic; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy*; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage*; D007328:Insulin / Q000008:administration & dosage*; D010349:Patient Compliance; D017060:Patient Satisfaction; D016032:Randomized Controlled Trials as Topic
chemical_list: C473734:Exubera; D007004:Hypoglycemic Agents; D007328:Insulin